0002122464-26-000007.txt : 20260408 0002122464-26-000007.hdr.sgml : 20260408 20260407173843 ACCESSION NUMBER: 0002122464-26-000007 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260408 DATE AS OF CHANGE: 20260407 EFFECTIVENESS DATE: 20260408 FILER: COMPANY DATA: COMPANY CONFORMED NAME: IMAGINOSTICS, INC. CENTRAL INDEX KEY: 0002122464 ORGANIZATION NAME: EIN: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-579104 FILM NUMBER: 26845927 BUSINESS ADDRESS: STREET 1: C/O GUIDEWELL INNOVATION CENTER STREET 2: 6555 SANGER RD, SUITE 100 CITY: ORLANDO STATE: FL ZIP: 32827 BUSINESS PHONE: 000-000-0000 MAIL ADDRESS: STREET 1: C/O GUIDEWELL INNOVATION CENTER STREET 2: 6555 SANGER RD, SUITE 100 CITY: ORLANDO STATE: FL ZIP: 32827 D/A 1 primary_doc.xml X0708 D/A LIVE 0002122464 IMAGINOSTICS, INC. C/O GUIDEWELL INNOVATION CENTER 6555 SANGER RD, SUITE 100 ORLANDO FL FLORIDA 32827 000-000-0000 DELAWARE None None Corporation true Valerie Aimee Gharagouzloo 6555 Sanger Rd, Suite 100 C/O GUIDEWELL INNOVATION CENTER Orlando FL FLORIDA 32827 Executive Officer Director Promoter Codi Gharagouzloo 6555 Sanger Rd, Suite 100 C/O GUIDEWELL INNOVATION CENTER ORLANDO FL FLORIDA 32827 Executive Officer Director Promoter Scott Hoge 6555 Sanger Rd, Suite 100 C/O GUIDEWELL INNOVATION CENTER Orlando FL FLORIDA 32827 Executive Officer Biotechnology No Revenues 06b true 0002122464-26-000004 2021-11-20 true true true true true These securities are Simple Agreements for Future Equity (SAFEs), which are convertible into equity securities of the issuer, typically preferred stock, upon the occurrence of specified triggering events, including future financing rounds. false 0 Indefinite 50000 Indefinite false 1 0 0 0 false IMAGINOSTICS, INC. Valerie Gharagouzloo Valerie Gharagouzloo CEO 2026-04-07